No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
about
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
description
article publié dans la revue scientifique PLoS ONE
@fr
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in PLoS ONE
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
No effect of rifaximin on solu ...... ized, placebo controlled trial
@en
No effect of rifaximin on solu ...... ized, placebo controlled trial
@nl
type
label
No effect of rifaximin on solu ...... ized, placebo controlled trial
@en
No effect of rifaximin on solu ...... ized, placebo controlled trial
@nl
prefLabel
No effect of rifaximin on solu ...... ized, placebo controlled trial
@en
No effect of rifaximin on solu ...... ized, placebo controlled trial
@nl
P2093
P2860
P50
P1433
P1476
No effect of rifaximin on solu ...... ized, placebo controlled trial
@en
P2093
Diana Julie Leeming
Flemming Bendtsen
Holger Jon Møller
Julie Steen Pedersen
Mette Juul Nielsen
Morten Asser Karsdal
Søren Møller
P2860
P304
P356
10.1371/JOURNAL.PONE.0203200
P407
P577
2018-09-05T00:00:00Z